I'm LongbridgeAI, I can summarize articles.Auna SA added 0.38% this week to close at $5.26, outperforming the S&P 500 by roughly 1.81 percentage points as the benchmark shed 1.43%. The week was volatile, with a 19.62% swing from trough to peak. Shares edged higher on Monday and Tuesday, then plunged to an intraday low of $4.60 on Wednesday before staging a sharp reversal to hit $5.64 — the highest level in 60 sessions. Thursday and Friday saw a modest pullback.
The Week
Auna SA added 0.38% this week to close at $5.26, outperforming the S&P 500 by roughly 1.81 percentage points as the benchmark shed 1.43%. The week was volatile, with a 19.62% swing from trough to peak. Shares edged higher on Monday and Tuesday, then plunged to an intraday low of $4.60 on Wednesday before staging a sharp reversal to hit $5.64 — the highest level in 60 sessions. Thursday and Friday saw a modest pullback. Daily volume averaged about 409k shares, more than double the 60-day median.
Key Events
The week was all about the second-quarter earnings release. Auna reported results after Tuesday’s close: revenue rose 13% year-on-year to S/ 1.24 billion, while net income dropped 60.71% to S/ 33 million. EPS missed consensus by $0.11. The company reaffirmed its full-year 2026 growth guidance and highlighted a 181% surge in free cash flow. Wednesday’s session was chaotic — the stock gapped down to $4.60 at the open, then rebounded as the earnings call detailed expansion of the high-complexity care network and strong cash generation. The shares closed that day up 0.18%. Post-call commentary flagged the tension between solid revenue growth and a 9% decline in FX-neutral adjusted EBITDA. The full transcript was published over the weekend.
Analyst Ratings
The latest consensus shows 7 analysts covering Auna: 4 rate it buy, 1 overweight, and 2 hold, with no underweight or sell ratings. The consensus recommendation is ‘buy’, and the consensus target price sits at $6.99, implying a roughly 32.81% upside from the current price. Target prices range from $5.00 to $9.00 — a wide spread that signals considerable disagreement over the pace of margin recovery. Within the healthcare facilities industry, Auna ranks 11th out of 20 peers by analyst rating.
The Week Ahead
No company-specific events are on the calendar next week. The focus will shift to macro data that could sway risk appetite. On Tuesday (25 August), the US releases a slate of housing and consumer data: FHFA and S&P Case-Shiller home price indices, the Conference Board consumer confidence index, and new home sales. The consumer confidence print is forecast at 90.1, slightly below the prior 90.8. A miss could weigh on sentiment for high-growth healthcare names like Auna.
In Short
Auna carved out a deep V-shaped recovery this week, closing slightly higher as the market rewarded top-line growth and cash flow improvement, while profitability headwinds kept a lid on valuations. The analyst community leans positive, and the consensus target offers a meaningful premium, though the wide target range signals that the bull and bear cases are far from settled. With a trailing P/E near 82.55x and a price-to-book ratio of just 0.71x, the valuation picture is mixed. Whether the stock can hold recent highs and break higher depends on its ability to absorb margin pressure in the quarters ahead.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.